Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy

J Natl Cancer Inst. 2011 Jul 6;103(13):1069; reply 1069-70. doi: 10.1093/jnci/djr191. Epub 2011 Jun 23.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Breast Neoplasms / chemically induced*
  • Breast Neoplasms / epidemiology*
  • Carcinoma, Ductal, Breast / chemically induced
  • Carcinoma, Ductal, Breast / epidemiology
  • Contraceptives, Oral, Hormonal / administration & dosage
  • Contraceptives, Oral, Hormonal / adverse effects*
  • Estrogen Replacement Therapy / adverse effects*
  • Estrogens / administration & dosage
  • Estrogens / adverse effects
  • Female
  • Humans
  • Menopause*
  • Middle Aged
  • Progestins / administration & dosage
  • Progestins / adverse effects
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • United Kingdom / epidemiology
  • United States / epidemiology
  • Women's Health

Substances

  • Contraceptives, Oral, Hormonal
  • Estrogens
  • Progestins